Living Cell Technologies Ltd. (AU:1AI) has released an update.
ALGORAE PHARMACEUTICALS LIMITED has announced its application for the quotation of 25 million newly vested ordinary shares on the ASX under the code 1AI. These shares, issued on December 28, 2023, are the result of the conversion of performance rights as detailed in a previous company notice. This move signifies a potential expansion in the company’s market presence, sparking interest among investors.
For further insights into AU:1AI stock, check out TipRanks’ Stock Analysis page.
